NCT07482657 A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus Status NOT_YET_RECRUITING Phase PHASE2
NCT07418229 Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine Status NOT_YET_RECRUITING Phase PHASE1
NCT07217639 Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings Status NOT_YET_RECRUITING Phase NA
NCT07147517 Preparedness Through Respiratory Virus Epidemiology and Community Engagement Status RECRUITING Phase N/A
NCT07097012 Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy Status RECRUITING Phase PHASE4
NCT07030075 SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIVIDUALS IN LUSAKA, ZAMBIA Status RECRUITING Phase N/A
NCT06684743 Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults Status RECRUITING Phase PHASE4
NCT06672692 A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients Status RECRUITING Phase NA
NCT06160128 Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA) Status RECRUITING Phase N/A
NCT05585632 A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old Status COMPLETED Phase PHASE1
NCT05096208 Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age Status COMPLETED Phase PHASE3
NCT01985620 The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate. Status UNKNOWN Phase NA